Mark explains some of the regulation trends in the EU, compared with those in the USA and also shares his thoughts on what advances in biotech regulations we can expect to see in the next decade.

While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

Physicists at Loughborough University have made an exciting breakthrough in understanding how to fine-tune the behavior of electrons in quantum materials poised to drive the next generation of ...

Kennedy Jr., invested in gene-editing technology and is owed substantial advances for several books ... including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics.

NEW YORK - IO Biotech (IOBT), a clinical-stage biopharmaceutical company valued at $58.63 million, has published results from a preclinical study on its second cancer vaccine candidate, IO112, which ...

Virginia Tech is leading the effort that aims to strengthen bonds between biomedical companies and sector leaders.

The synthetic chromosome includes features that enable researchers to generate genetic diversity on demand, accelerating the development of yeasts with enhanced capabilities for biotechnology ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated ...

Moleculin Biotech announced significant progress in the development of its drug Annamycin, particularly for relapsed or refractory acute myeloid leukemia (AML). The company has received approval ...

Some 4,000 biotech industry businesses employ about 40,000 workers at well-above-average wages, with ripple effects across ...

today announced significant advances in its biotechnology breeding program and a groundbreaking partnership during the 4th Sanya International Seed Industry Scientist Conference and 2025 ...

(RTTNews) - Fortress Biotech, Inc. (FBIO), a biopharmaceutical company, announced on Monday that the first patient has been dosed in its Phase 2 clinical trial to evaluate the Triplex vaccine in ...